Click for best price
Minimally Invasive Treatment of Lung Cancer Market Size, Share 2023
The minimally invasive treatment method for lung cancer is to cut relatively small wounds around the lung, and then perform local resection through thoracoscopy. The skin injury is relatively small during the operation, and the recovery period after the operation will be very short.
This report aims to provide a comprehensive presentation of the global market for Minimally Invasive Treatment of Lung Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Minimally Invasive Treatment of Lung Cancer. This report contains market size and forecasts of Minimally Invasive Treatment of Lung Cancer in global, including the following market information:
Global Minimally Invasive Treatment of Lung Cancer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Minimally Invasive Treatment of Lung Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Lung Tumor Ablation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Minimally Invasive Treatment of Lung Cancer include Medtronic, Olympus, LungCare, Broncus, Intuitive Surgica, Auris Health, Angiodynamics, Boston Scientific and Smith and Nephew, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Minimally Invasive Treatment of Lung Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Minimally Invasive Treatment of Lung Cancer Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, by Type, 2022 (%)
Lung Tumor Ablation
Lung Tumor Embolization
Global Minimally Invasive Treatment of Lung Cancer Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Global Minimally Invasive Treatment of Lung Cancer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Minimally Invasive Treatment of Lung Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Minimally Invasive Treatment of Lung Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Olympus
LungCare
Broncus
Intuitive Surgica
Auris Health
Angiodynamics
Boston Scientific
Smith and Nephew
VISON Medical
Nanjing MICRO-TECH
Outline of Major Chapters:
Chapter 1: Introduces the definition of Minimally Invasive Treatment of Lung Cancer, market overview.
Chapter 2: Global Minimally Invasive Treatment of Lung Cancer market size in revenue.
Chapter 3: Detailed analysis of Minimally Invasive Treatment of Lung Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Minimally Invasive Treatment of Lung Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Minimally Invasive Treatment of Lung Cancer Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Minimally Invasive Treatment of Lung Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Minimally Invasive Treatment of Lung Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Minimally Invasive Treatment of Lung Cancer Overall Market Size
2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size: 2022 VS 2029
2.2 Global Minimally Invasive Treatment of Lung Cancer Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Minimally Invasive Treatment of Lung Cancer Players in Global Market
3.2 Top Global Minimally Invasive Treatment of Lung Cancer Companies Ranked by Revenue
3.3 Global Minimally Invasive Treatment of Lung Cancer Revenue by Companies
3.4 Top 3 and Top 5 Minimally Invasive Treatment of Lung Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Minimally Invasive Treatment of Lung Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Minimally Invasive Treatment of Lung Cancer Players in Global Market
3.6.1 List of Global Tier 1 Minimally Invasive Treatment of Lung Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Minimally Invasive Treatment of Lung Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Minimally Invasive Treatment of Lung Cancer Market Size Markets, 2022 & 2029
4.1.2 Lung Tumor Ablation
4.1.3 Lung Tumor Embolization
4.2 By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
4.2.1 By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
4.2.2 By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2024-2029
4.2.3 By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Minimally Invasive Treatment of Lung Cancer Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.2 By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
5.2.1 By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
5.2.2 By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2024-2029
5.2.3 By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Minimally Invasive Treatment of Lung Cancer Market Size, 2022 & 2029
6.2 By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
6.2.1 By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
6.2.2 By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2024-2029
6.2.3 By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.3.2 US Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.3.3 Canada Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.3.4 Mexico Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.4.2 Germany Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.3 France Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.4 U.K. Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.5 Italy Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.6 Russia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.7 Nordic Countries Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.8 Benelux Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.5.2 China Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.3 Japan Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.4 South Korea Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.5 Southeast Asia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.6 India Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.6.2 Brazil Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.6.3 Argentina Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.7.2 Turkey Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7.3 Israel Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7.4 Saudi Arabia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7.5 UAE Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
7 Minimally Invasive Treatment of Lung Cancer Companies Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.1.4 Medtronic Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Olympus
7.2.1 Olympus Company Summary
7.2.2 Olympus Business Overview
7.2.3 Olympus Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.2.4 Olympus Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.2.5 Olympus Key News & Latest Developments
7.3 LungCare
7.3.1 LungCare Company Summary
7.3.2 LungCare Business Overview
7.3.3 LungCare Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.3.4 LungCare Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.3.5 LungCare Key News & Latest Developments
7.4 Broncus
7.4.1 Broncus Company Summary
7.4.2 Broncus Business Overview
7.4.3 Broncus Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.4.4 Broncus Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.4.5 Broncus Key News & Latest Developments
7.5 Intuitive Surgica
7.5.1 Intuitive Surgica Company Summary
7.5.2 Intuitive Surgica Business Overview
7.5.3 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.5.4 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.5.5 Intuitive Surgica Key News & Latest Developments
7.6 Auris Health
7.6.1 Auris Health Company Summary
7.6.2 Auris Health Business Overview
7.6.3 Auris Health Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.6.4 Auris Health Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.6.5 Auris Health Key News & Latest Developments
7.7 Angiodynamics
7.7.1 Angiodynamics Company Summary
7.7.2 Angiodynamics Business Overview
7.7.3 Angiodynamics Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.7.4 Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.7.5 Angiodynamics Key News & Latest Developments
7.8 Boston Scientific
7.8.1 Boston Scientific Company Summary
7.8.2 Boston Scientific Business Overview
7.8.3 Boston Scientific Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.8.4 Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.8.5 Boston Scientific Key News & Latest Developments
7.9 Smith and Nephew
7.9.1 Smith and Nephew Company Summary
7.9.2 Smith and Nephew Business Overview
7.9.3 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.9.4 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.9.5 Smith and Nephew Key News & Latest Developments
7.10 VISON Medical
7.10.1 VISON Medical Company Summary
7.10.2 VISON Medical Business Overview
7.10.3 VISON Medical Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.10.4 VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.10.5 VISON Medical Key News & Latest Developments
7.11 Nanjing MICRO-TECH
7.11.1 Nanjing MICRO-TECH Company Summary
7.11.2 Nanjing MICRO-TECH Business Overview
7.11.3 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.11.4 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.11.5 Nanjing MICRO-TECH Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Minimally Invasive Treatment of Lung Cancer Market Opportunities & Trends in Global Market
Table 2. Minimally Invasive Treatment of Lung Cancer Market Drivers in Global Market
Table 3. Minimally Invasive Treatment of Lung Cancer Market Restraints in Global Market
Table 4. Key Players of Minimally Invasive Treatment of Lung Cancer in Global Market
Table 5. Top Minimally Invasive Treatment of Lung Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Minimally Invasive Treatment of Lung Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Minimally Invasive Treatment of Lung Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Minimally Invasive Treatment of Lung Cancer Product Type
Table 9. List of Global Tier 1 Minimally Invasive Treatment of Lung Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Minimally Invasive Treatment of Lung Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 30. Medtronic Company Summary
Table 31. Medtronic Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 32. Medtronic Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Medtronic Key News & Latest Developments
Table 34. Olympus Company Summary
Table 35. Olympus Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 36. Olympus Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. Olympus Key News & Latest Developments
Table 38. LungCare Company Summary
Table 39. LungCare Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 40. LungCare Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. LungCare Key News & Latest Developments
Table 42. Broncus Company Summary
Table 43. Broncus Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 44. Broncus Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Broncus Key News & Latest Developments
Table 46. Intuitive Surgica Company Summary
Table 47. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 48. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Intuitive Surgica Key News & Latest Developments
Table 50. Auris Health Company Summary
Table 51. Auris Health Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 52. Auris Health Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Auris Health Key News & Latest Developments
Table 54. Angiodynamics Company Summary
Table 55. Angiodynamics Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 56. Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Angiodynamics Key News & Latest Developments
Table 58. Boston Scientific Company Summary
Table 59. Boston Scientific Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 60. Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. Boston Scientific Key News & Latest Developments
Table 62. Smith and Nephew Company Summary
Table 63. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 64. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. Smith and Nephew Key News & Latest Developments
Table 66. VISON Medical Company Summary
Table 67. VISON Medical Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 68. VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 69. VISON Medical Key News & Latest Developments
Table 70. Nanjing MICRO-TECH Company Summary
Table 71. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 72. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 73. Nanjing MICRO-TECH Key News & Latest Developments
List of Figures
Figure 1. Minimally Invasive Treatment of Lung Cancer Segment by Type in 2022
Figure 2. Minimally Invasive Treatment of Lung Cancer Segment by Application in 2022
Figure 3. Global Minimally Invasive Treatment of Lung Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Minimally Invasive Treatment of Lung Cancer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Minimally Invasive Treatment of Lung Cancer Revenue in 2022
Figure 8. By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 9. By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 10. By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 12. By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 14. By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 15. By Country - North America Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 16. US Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 20. Germany Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 21. France Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 28. China Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 32. India Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 34. Brazil Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 37. Turkey Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 41. Medtronic Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Olympus Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. LungCare Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Broncus Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Auris Health Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
